C12N 2710/24044
Chimeric viral vector comprising heterologous viral elements for production of another viral
Official title: Chimeric viral vector comprising heterologous viral elements for production of another viral vector
C12N2710/24044 (Chimeric viral vector comprising heterologous viral elements for production of another viral) appears on 4 US grants and 2 published applications in this corpus.
Search patents in C12N- Granted patents
- 4
- Published applications
- 2
- Assignees
- 5
- Inventors
- 8
- Latest grant
- 2 Jan 2018
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1997 | 1 | 0 |
| 1998 | 1 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 1 |
| 2014 | 1 | 0 |
| 2015 | 0 | 1 |
| 2016 | 0 | 0 |
| 2017 | 0 | 0 |
| 2018 | 1 | 0 |
By publication year. Applications have been published since 2001.
Recent patents
- Recombinant feline leukemia virus vaccine containing optimized feline leukemia virus envelope gene2 Jan 2018US 9,856,295 B2Merial Limited
- Recombinant feline leukemia virus vaccine containing optimized feline leukemia virus envelope gene25 Nov 2014US 8,895,027 B2Centre National De La Recherche Scientifique
- Self assembled, defective, nonself-propagating viral particles8 Sep 1998US 5,804,196 ATherion Biologics Corporation
- Self assembled, defective, non-self-propagating lentivirus particles20 May 1997US 5,631,154 ATherion Biologics Corporation
- Recombinant Feline Leukemia Virus Vaccine Containing Optimized Feline Leukemia Virus Envelope Gene29 Jan 2015US 2015/0030623 A1Centre National De La Recherche Scientifique
- Recombinant feline leukemia virus vaccine containing optimized feline leukemia virus envelope gene24 Jan 2013US 2013/0022632 A1Centre National De La Recherche Scientifique
Most cited
By later US patents